Fluconazole in patients at risk from invasive aspergillosis.
We report on four cases of aspergillosis which developed during therapy with fluconazole in patients who were immunosuppressed or granulocytopenic. Fluconazole may obscure the onset of aspergillosis. We feel that it should neither be given prophylactically nor for fever of unknown origin in patients who are at high risk of contracting aspergillosis.
Kappe
R
R
Department of Medicine, University of Heidelberg, Germany.
Osterziel
K J
KJ
Rüchel
R
R
Siehl
S
S
D000328:Adult; D000380:Agranulocytosis / Q000150:complications; D001228:Aspergillosis / Q000139:chemically induced* / Q000517:prevention & control; D005260:Female; D015725:Fluconazole / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000517:prevention & control; D012307:Risk Factors
D015725:Fluconazole